Cargando…

The Improving Risk Informed HPV Screening (IRIS) Study: Design and Baseline Characteristics

BACKGROUND: Cervical cancer screening with high-risk human papillomavirus (HrHPV) testing is being introduced. Most HrHPV infections are transient, requiring triage tests to identify individuals at highest risk for progression to cervical cancer. Head-to-head comparisons of available strategies for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gage, Julia C., Raine-Bennett, Tina, Schiffman, Mark, Clarke, Megan A., Cheung, Li C., Poitras, Nancy E., Varnado, Nicole E., Katki, Hormuzd A., Castle, Philip E., Befano, Brian, Chandra, Malini, Rydzak, Greg, Lorey, Thomas, Wentzensen, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175306/ https://www.ncbi.nlm.nih.gov/pubmed/34789470 http://dx.doi.org/10.1158/1055-9965.EPI-21-0865

Ejemplares similares

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting
por: Landy, Rebecca, et al.
Publicado: (2019)

Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines
por: Egemen, Didem, et al.
Publicado: (2020)

A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines
por: Demarco, Maria, et al.
Publicado: (2020)

Low Risk of Cervical Cancer/Precancer Among Most Women Under Surveillance Postcolposcopy
por: Demarco, Maria, et al.
Publicado: (2018)

A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs
por: Demarco, Maria, et al.
Publicado: (2020)

Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines
por: Demarco, Maria, et al.
Publicado: (2017)

Genetic and Epigenetic Variations of HPV52 in Cervical Precancer
por: Bee, Katharine J., et al.
Publicado: (2021)

2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation
por: Cheung, Li C., et al.
Publicado: (2020)

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program
por: Wentzensen, Nicolas, et al.
Publicado: (2019)

Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection
por: Cullen, Michael, et al.
Publicado: (2015)

Issues in optimising and standardising the accuracy and utility of the colposcopic examination in the HPV era
por: Schiffman, Mark, et al.
Publicado: (2015)

Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance
por: Zhu, Bin, et al.
Publicado: (2020)

Incorporating medical interventions into carrier probability estimation for genetic counseling
por: Katki, Hormuzd A
Publicado: (2007)

Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women()
por: Clifford, Gary M., et al.
Publicado: (2019)

Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica
por: Herrero, Rolando, et al.
Publicado: (2013)

The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis
por: Mirabello, Lisa, et al.
Publicado: (2018)

Accuracy and Efficiency of Deep-Learning–Based Automation of Dual Stain Cytology in Cervical Cancer Screening
por: Wentzensen, Nicolas, et al.
Publicado: (2020)

Viral coinfection analysis using a MinHash toolkit
por: Dawson, Eric T., et al.
Publicado: (2019)

Effectiveness of VIA, Pap, and HPV DNA Testing in a Cervical Cancer Screening Program in a Peri-Urban Community in Andhra Pradesh, India
por: Gravitt, Patti E., et al.
Publicado: (2010)

Variation in Human Papillomavirus Vaccination Effectiveness in the US by Age at Vaccination
por: Egemen, Didem, et al.
Publicado: (2022)

Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals
por: Landy, Rebecca, et al.
Publicado: (2023)

Redesign of a rapid, low‐cost HPV typing assay to support risk‐based cervical screening and management
por: Desai, Kanan T., et al.
Publicado: (2022)

Phylogenomic Analysis of Human Papillomavirus Type 31 and Cervical Carcinogenesis: A Study of 2093 Viral Genomes
por: Pinheiro, Maisa, et al.
Publicado: (2021)

Somatic Host Cell Alterations in HPV Carcinogenesis
por: Litwin, Tamara R., et al.
Publicado: (2017)

Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials
por: Wacholder, Sholom, et al.
Publicado: (2010)

HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer
por: Zuna, Rosemary E, et al.
Publicado: (2011)

Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial
por: Panagiotou, Orestis A, et al.
Publicado: (2015)

Cervicovaginal microbiome and natural history of HPV in a longitudinal study
por: Usyk, Mykhaylo, et al.
Publicado: (2020)

Design and feasibility of a novel program of cervical screening in Nigeria: self-sampled HPV testing paired with visual triage
por: Desai, Kanan T., et al.
Publicado: (2020)

Evolution and Taxonomic Classification of Alphapapillomavirus 7 Complete Genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70
por: Chen, Zigui, et al.
Publicado: (2013)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

Cervical Screening Performance
por: Schiffman, Mark, et al.
Publicado: (2021)

Genome assembly of the bearded iris, Iris pallida Lam.
por: Bruccoleri, Robert E., et al.
Publicado: (2023)

Network Visualization and Pyramidal Feature Comparison for Ablative Treatability Classification Using Digitized Cervix Images
por: Guo, Peng, et al.
Publicado: (2021)

A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria
por: Clarke, Megan A, et al.
Publicado: (2011)

HPV16 E7 Nucleotide Variants Found in Cancer-Free Subjects Affect E7 Protein Expression and Transformation
por: Lou, Hong, et al.
Publicado: (2022)

The cat with abnormal iris appearance
por: Bernays, Michael E.
Publicado: (2006)

“I'm not a freshi”: Culture shock, puberty and growing up as British-Bangladeshi girls
por: Houghton, Lauren C., et al.
Publicado: (2020)

False positive cervical HPV screening test results
por: Schiffman, Mark, et al.
Publicado: (2019)

HPV16 Seropositivity and Subsequent HPV16 Infection Risk in a Naturally Infected Population: Comparison of Serological Assays
por: Lin, Shih-Wen, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_r5tj9cok3bgqtp0jhd1fqkv49n